Two leading non-profits combine efforts to accelerate cancer immunotherapy for patients globally
First-of-its-kind analysis of the global immuno-oncology clinical landscape from pre-clinical development to regulatory approval provides unprecedented opportunity to advance the field of immuno-oncology to improve patient care.
Fight Colorectal Cancer, Cancer Research Institute announce Cancer Immunology Research article publication discussing CRC immunotherapy advancement
The Cancer Research Institute announced today that it will honor biotechnology company Genentech and real estate developer and philanthropist Bruce Ratner with the 2017 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
Drs. Rafi Ahmed and Thomas F. Gajewski will receive the 2017 William B. Coley Award, and Dr. Shannon Turley will receive the 2017 Frederick W. Alt Award.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Immunotherapy tripled the median progression-free survival rate among lung cancer patients compared to those who received only chemotherapy and radiation
We introduce you to Thomas Hudson, M.D., vice president, head of oncology discovery and early development at AbbVie.